First-Line A Direct Aspiration First-Pass Technique vs. First-Line Stent Retriever for Acute Ischemic Stroke Therapy: A Meta-Analysis

作者
Kevin Li‐Chun Hsieh,Kai-I Chuang,Hsu‐Huei Weng,Sho‐Jen Cheng,Yu Chiang,Cheng‐Yu Chen
出处
期刊:Frontiers in Neurology [Frontiers Media]
卷期号:9: 801-801 被引量:13
标识
DOI:10.3389/fneur.2018.00801
摘要

Backround Recent trials have proved the efficacy of mechanical thrombectomy over medical treatment for patients with acute ischemic stroke, with the balance of equivalent rates of adverse events. Stent retrievers were applied predominantly in most trials; however, the role of other thrombectomy devices has not been well validated. A direct aspiration first-pass technique (ADAPT) is proposed to be a faster thrombectomy technique than the stent retriever technique. This meta-analysis investigated and compared the efficacy and adverse events of first-line ADAPT with those of first-line stent retrievers in patients with acute ischemic stroke. Methods A structured search was conducted comprehensively. A total of 1623 papers were found, and 4 articles were included in our meta-analysis. The Critical Appraisal Skills Programme tools were applied to evaluate the quality of studies. The primary outcome was defined as the proportion of patients with the Thrombolysis in Cerebral Ischemia (TICI) scale of 2b/3 at the end of all procedures. Secondary outcomes were the proportion of patients with functional independence (modified Rankin scale of 0-2) at the third month, the proportion of patients with the Thrombolysis in Cerebral Ischemia (TICI) scale of 2b/3 by primary chosen device, and the proportion of patients who received rescue therapies. Safety outcomes were the symptomatic intracranial hemorrhage (sICH) rate and the mortality rate within 3 months. Results One randomized controlled trial, one prospective cohort study, and two retrospective cohort studies were included. No significant difference between these 2 strategies of management were observed in the primary outcome (TICI scale at the end of all procedures, odds ratio [OR] = 0.78), two secondary outcomes (functional independence at the third month, OR = 1.16; TICI scale by primary chosen device, OR = 1.25), and all safety outcomes (sICH rate, OR = 1.56; mortality rate, OR = 0.91). The proportion of patients who received rescue therapies was higher in the first-line ADAPT group (OR = 0.64). Conclusions Among first-line thrombectomy devices for patients with ischemic stroke, ADAPT with the latest thrombosuction system was as efficient and safe as stent retrievers.

科研通智能强力驱动
Strongly Powered by AbleSci AI
科研通是完全免费的文献互助平台,具备全网最快的应助速度,最高的求助完成率。 对每一个文献求助,科研通都将尽心尽力,给求助人一个满意的交代。
实时播报
1秒前
轻松雅青完成签到,获得积分10
1秒前
lingudu完成签到,获得积分10
1秒前
1秒前
2秒前
2秒前
李健的应助被将月采纳,获得10
3秒前
Sarah发布了新的文献求助10
3秒前
Ava的应助被爱浦西的迪克采纳,获得10
5秒前
Xenophobia发布了新的文献求助10
5秒前
彭淑华完成签到,获得积分10
6秒前
j杰发布了新的文献求助30
6秒前
冀晓梦发布了新的文献求助10
6秒前
lllllria的应助被niania采纳,获得10
7秒前
南音发布了新的文献求助10
7秒前
是R同学哦发布了新的文献求助10
8秒前
8秒前
8秒前
9秒前
强子完成签到,获得积分10
10秒前
Tbq完成签到,获得积分10
10秒前
大耳萌图发布了新的文献求助10
11秒前
hyh完成签到,获得积分10
11秒前
sss完成签到,获得积分10
11秒前
12秒前
李健的应助被DW采纳,获得10
12秒前
Famiglistmo完成签到,获得积分10
12秒前
12秒前
泗泗发布了新的文献求助10
12秒前
13秒前
认真初之完成签到,获得积分10
13秒前
xiaoqian的应助被沉默便当采纳,获得10
15秒前
万万使不得完成签到,获得积分10
16秒前
Tbq发布了新的文献求助10
16秒前
葱峰完成签到 ,获得积分10
17秒前
橙子发布了新的文献求助10
18秒前
19秒前
Xenophobia完成签到,获得积分10
19秒前
脑洞疼的应助被泗泗采纳,获得10
20秒前
如意白猫完成签到 ,获得积分10
21秒前
高分求助中
(应助此贴封号)【重要!!请各用户(尤其是新用户)详细阅读】【科研通的精品贴汇总】 10000
Energie-Contracting 1500
Klimaschutzrecht durch den Energiesektor im Mehrebenensystem – Ein Rechtsvergleich 1000
Représentation chimique de la structure des kérogènes et des asphaltènes en fonction de leur origine et de leur degré d'évolution 800
Oncology Clinical Trials: Successful Design, Conduct, and Analysis, Second Edition 800
Stochastic Models in Operations Research,Vol. 2 600
Organizational Behavior 510
热门求助领域 (近24小时)
化学 材料科学 医学 生物 纳米技术 计算机科学 工程类 有机化学 化学工程 生物化学 物理 复合材料 内科学 催化作用 光电子学 人工智能 细胞生物学 无机化学 物理化学 数学
热门帖子
关注 科研通微信公众号,转发送积分 8054031
求助须知:如何正确求助?哪些是违规求助? 9481097
关于积分的说明 21305549
捐赠科研通 7622039
什么是DOI,文献DOI怎么找? 3394140
关于科研通互助平台的介绍 2525052
邀请新用户注册赠送积分活动 2432207